Correction

Published on 06 Sep 2023

Corrigendum: The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma

in Cancer Immunity and Immunotherapy

Zhimin Zeng
Xiaoying Qian
Fanrong Liu
Yong Wang
Yong Yuan
Chen Fang
Xinwei Zhang
Shangkun Yuan
Renfang Chen
Biao Yu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1269596

534 views

Original Research

Published on 06 Sep 2023

Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer

in Cancer Immunity and Immunotherapy

Brandon Mistretta
Sakuni Rankothgedera
Micah Castillo
Mitchell Rao
Kimberly Holloway
Anjana Bhardwaj
Maha El Noafal
Constance Albarracin
Randa El-Zein
Hengameh Rezaei

Frontiers in Immunology

doi 10.3389/fimmu.2023.1188831

1,619 views

Original Research

Published on 06 Sep 2023

TAGAP expression influences CD4+ T cell differentiation, immune infiltration, and cytotoxicity in LUAD through the STAT pathway: implications for immunotherapy

in Cancer Immunity and Immunotherapy

Zhanyu Xu
Tiaozhan Zheng
Zhiwen Zheng
Wei Jiang
Liuliu Huang
Kun Deng
Liqiang Yuan
Fanglu Qin
Yu Sun
Junqi Qin

Frontiers in Immunology

doi 10.3389/fimmu.2023.1224340

2,820 views

Review

Published on 06 Sep 2023

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities

in Cancer Immunity and Immunotherapy

Bolin Wang
Jinli Pei
Shengnan Xu
Jie Liu
Jinming Yu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1246682

6,582 views
1 citation

Review

Accepted on 04 Sep 2023

Experimental and clinical evidence in favor of an effective immune stimulation in ER-positive, endocrine-dependent metastatic breast cancer

in Cancer Immunity and Immunotherapy

Andrea Nicolini
Giuseppe Rossi
Paola Ferrari

Frontiers in Immunology

doi 10.3389/fimmu.2023.1225175

113 views

Original Research

Published on 04 Sep 2023

Improvement in neoantigen prediction via integration of RNA sequencing data for variant calling

in Cancer Immunity and Immunotherapy

Bui Que Tran Nguyen
Thi Phuong Diem Tran
Huu Thinh Nguyen
Thanh Nhan Nguyen
Thi Mong Quynh Pham
Hoang Thien Phuc Nguyen
Duc Huy Tran
Vy Nguyen
Thanh Sang Tran
Truong-Vinh Ngoc Pham

Frontiers in Immunology

doi 10.3389/fimmu.2023.1251603

2,001 views
1 citation

Review

Published on 04 Sep 2023

The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma

in Cancer Immunity and Immunotherapy

Lingyun Zhang
Yu Jiang
Gao Zhang
Shiyou Wei

Frontiers in Immunology

doi 10.3389/fimmu.2023.1238233

2,681 views
1 citation

Original Research

Published on 04 Sep 2023

Cost-effectiveness analysis of dostarlimab plus carboplatin-paclitaxel as first-line treatment for advanced endometrial cancer

in Cancer Immunity and Immunotherapy

Maojin You
Xiaoling Zeng
Jinrong Zhang
Yufan Huang
Yalan Zhang
Zhongjie Cai
Yingying Hu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1267322

1,368 views

Brief Research Report

Published on 04 Sep 2023

Sequencing-based transcriptome analysis reveals diversification of immune response- and angiogenesis-related expression patterns of early-stage cervical carcinoma as compared with high-grade CIN

in Cancer Immunity and Immunotherapy

Olga V. Kurmyshkina
Pavel V. Dobrynin
Pavel I. Kovchur
Tatyana O. Volkova

Frontiers in Immunology

doi 10.3389/fimmu.2023.1215607

1,366 views
1 citation

Retraction

Published on 04 Sep 2023

Retraction: Harnessing TRAIL-induced apoptosis pathway for cancer immunotherapy and associated challenges

in Cancer Immunity and Immunotherapy

Frontiers Editorial Office

Frontiers in Immunology

doi 10.3389/fimmu.2023.1285126

728 views

Retraction

Published on 04 Sep 2023

Retraction: A deep insight into CAR-T cell therapy in non-Hodgkin lymphoma: application, opportunities, and future directions

in Cancer Immunity and Immunotherapy

Frontiers Editorial Office

Frontiers in Immunology

doi 10.3389/fimmu.2023.1285110

1,116 views

Original Research

Published on 04 Sep 2023

Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer

in Cancer Immunity and Immunotherapy

Renhong Huang
Han Wang
Jin Hong
Jiayi Wu
Ou Huang
Jianrong He
Weiguo Chen
Yafen Li
Xiaosong Chen
Kunwei Shen

Frontiers in Immunology

doi 10.3389/fimmu.2023.1251643

2,108 views

Review

Published on 04 Sep 2023

Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions

in Cancer Immunity and Immunotherapy

Dandan Wu
Xuehui Chen
Shuqiu Zhou
Bin Li

Frontiers in Immunology

doi 10.3389/fimmu.2023.1241791

1,944 views

Original Research

Published on 01 Sep 2023

Escherichia coli adhesion portion FimH polarizes M2 macrophages to M1 macrophages in tumor microenvironment via toll-like receptor 4

in Cancer Immunity and Immunotherapy

Wei Zhang
Li Xu
Xiaoyan Zhang
Jianqing Xu
Jun-O Jin

Frontiers in Immunology

doi 10.3389/fimmu.2023.1213467

1,634 views

Review

Published on 01 Sep 2023

Immunotherapies targeting tumor vasculature: challenges and opportunities

in Cancer Immunity and Immunotherapy

Hassan Dianat-Moghadam
Reza Nedaeinia
Mohsen Keshavarz
Mehdi Azizi
Mohammad Kazemi
Rasoul Salehi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1226360

1,865 views

Review

Published on 01 Sep 2023

The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies

in Cancer Immunity and Immunotherapy

Jiuhui Xu
Qianyu Shi
Boyang Wang
Tao Ji
Wei Guo
Tingting Ren
Xiaodong Tang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1257254

1,634 views

Navigation group

Articles

Corrigendum: The efficacy and safety analysis of first-line immune checkpoint inhibitors in pulmonary sarcomatoid carcinoma

Chimeric RNAs reveal putative neoantigen peptides for developing tumor vaccines for breast cancer

TAGAP expression influences CD4+ T cell differentiation, immune infiltration, and cytotoxicity in LUAD through the STAT pathway: implications for immunotherapy

Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities

Experimental and clinical evidence in favor of an effective immune stimulation in ER-positive, endocrine-dependent metastatic breast cancer

Improvement in neoantigen prediction via integration of RNA sequencing data for variant calling

The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma

Cost-effectiveness analysis of dostarlimab plus carboplatin-paclitaxel as first-line treatment for advanced endometrial cancer

Sequencing-based transcriptome analysis reveals diversification of immune response- and angiogenesis-related expression patterns of early-stage cervical carcinoma as compared with high-grade CIN

Retraction: Harnessing TRAIL-induced apoptosis pathway for cancer immunotherapy and associated challenges

Retraction: A deep insight into CAR-T cell therapy in non-Hodgkin lymphoma: application, opportunities, and future directions

Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer

Reactive oxidative species (ROS)-based nanomedicine for BBB crossing and glioma treatment: current status and future directions

Escherichia coli adhesion portion FimH polarizes M2 macrophages to M1 macrophages in tumor microenvironment via toll-like receptor 4

Immunotherapies targeting tumor vasculature: challenges and opportunities

The role of tumor immune microenvironment in chordoma: promising immunotherapy strategies